Eckert & Ziegler Receives Approval for Gallium-68 Generator for Canada
Eckert & Ziegler Radiopharma GmbH has received approval for its pharmaceutical 68Ge/68Ga generator GalliaPharm® from the Canadian regulatory authority Health Canada.
“We are pleased to now be able to offer GalliaPharm® in Canada. Meanwhile, the generators from Eckert & Ziegler are available in more and more countries. If gallium-based diagnostics become widely accepted in the coming years, we are well prepared as supplier”, explains Dr. Lutz Helmke, member of the Executive Board of Eckert & Ziegler AG and responsible for the Medical segment. “Since there are currently many clinical studies with so-called theranostics worldwide, we expect an increasing demand for both the diagnostic radioisotope gallium-68 and the therapeutic radioisotope lutetium-177 in the next few years”.
To read the full press release, please refer to www.ezag.com